Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Changdian Pharmaceutical Co., Ltd. is a specialized pharmaceutical company based in Hangzhou, China, that focuses on the research, development, and manufacturing of anti-infective drugs, particularly in the penicillin and cephalosporin categories. The company is a significant producer of Piperacillin and Tazobactam, which are critical for treating severe bacterial infections in clinical settings. Zhejiang Changdian Pharmaceutical operates modern, GMP-compliant facilities and provides both active pharmaceutical ingredients (APIs) and finished dosage forms to domestic and international markets. Beyond its antibiotic portfolio, the company also develops and manufactures clinical nutrition products, such as compound amino acid injections. Its business model emphasizes high-quality manufacturing and process innovation to support the global supply of essential medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Changdian Pharmaceutical.